Bioassay Equivalent Concentration

Bioassay Equivalent Concentration (BEQ or BEC) is an estimate of the concentration of a reference chemical that would produce the same biological response as a complex environmental sample. It is determined by comparing the sample’s activity with a concentration-response curve generated from a known standard in a bioassay, often using receptor activation or another measured cellular effect. This approach converts combined activity from multiple contaminants into a common, biologically meaningful value. Environmental scientists use BECs to screen water, sediment, food, and biological tissues, compare contamination among samples, and assess potential risks when chemical analysis alone cannot capture mixture effects.

Bioassay Equivalent Concentration - Related Videos

Research

JoVE Journal - Biology
Free Sample

Bioassays for Monitoring Insecticide Resistance

0 Views •

Cited by 45 •

2010

This manuscript demonstrates and discusses techniques used to survey pesticide susceptibility and detect resistance to contact and systemic pesticides in arthropod pests.

Research

JoVE Journal - Biology

Bone Conditioned Medium: Preparation and Bioassay

0 Views •

Cited by 13 •

2015

We describe here how to prepare bone-conditioned medium (BCM) and test its activity in vitro.

Screening for Endocrine Activity in Water Using Commercially-available In Vitro Transactivation Bioassays

0 Views •

Cited by 12 •

2016

A protocol to screen for endocrine activity in organic extracts of water samples, including treated wastewater effluent and surface (receiving) water, was adapted using commercially available division-arrested ("freeze and thaw") in vitro transactivation bioassays.

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

0 Views •

Cited by 7 •

2016

We describe a simple cell-based bioassay for detecting, quantifying and monitoring the activity of members of the vascular endothelial growth factor family of ligands. The assay uses chimeric receptors expressed in a factor-dependent cell line to provide a semi-quantitative or quantitative assessment of receptor binding and cross-linking by the ligand.

Education

JoVE Core - Pharmacokinetics and Pharmacodynamics

Pharmaceutical Equivalents

0 Views •

2025

As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.

View All Results

FAQs

Related Topics